AGER and breast cancer: Therefore, in order to provide novel insights on the role of RAGE in ER-positive BC, we engineered MCF7 and T47D BC cells to stably overexpress RAGE (MCF7/RAGE and T47D/RAGE cells), as detailed in the methods section.